Skip to main content
SpringerLink
Log in
Book cover

Imaging in Pediatric Oncology pp 137–155Cite as

Contrast-Enhanced Ultrasound: The Current State

  • Chapter
  • First Online:

Part of the book series: Pediatric Oncology ((PEDIATRICO))

Abstract

Contrast-enhanced ultrasound (CEUS) is being increasingly recognized as an important method of imaging a variety of adult malignancies involving the liver, breast, prostate, and kidneys. Children are the ideal patient population for CEUS for a number of reasons including avoidance of exposure to ionizing radiation and sedation. However, because these agents were initially approved for use only in adult cardiology, less is known of their potential value in children. In 2016, the United States Federal Drug Administration approved the first ultrasound contrast agent for use in imaging liver lesions in both adults and children. This approval ushers in a new era for the growth and development of CEUS in children in a number of clinical settings. In this chapter experts in pediatric CEUS from the United States and Europe will discuss the important safety and technical aspects of CEUS and describe their experience with this modality in the setting of pediatric oncology. Future directions of CEUS in pediatric oncology will be addressed.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Berrington de Gonzalez A, Salotti JA, McHugh K, et al. Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions. Br J Cancer. 2016;114(4):388–94.

    Article  Google Scholar 

  2. Tibussek D, Rademacher C, Caspers J, et al. Gadolinium brain deposition after macrocyclic gadolinium administration: a pediatric case-control study. Radiology. 2017;285:223.

    Article  Google Scholar 

  3. Yusuf GT, Sellars ME, Deganello A, Cosgrove DO, Sidhu PS. Retrospective analysis of the safety and cost implications of pediatric contrast-enhanced ultrasound at a single center. AJR Am J Roentgenol. 2017;208(2):446–52.

    Article  Google Scholar 

  4. Piskunowicz M, Kosiak W, Batko T, Piankowski A, Polczynska K, Adamkiewicz-Drozynska E. Safety of intravenous application of second-generation ultrasound contrast agent in children: prospective analysis. Ultrasound Med Biol. 2015;41(4):1095–9.

    Article  Google Scholar 

  5. Coleman JL, Navid F, Furman WL, McCarville MB. Safety of ultrasound contrast agents in the pediatric oncologic population: a single-institution experience. AJR Am J Roentgenol. 2014;202(5):966–70.

    Article  Google Scholar 

  6. Jacob J, Deganello A, Sellars ME, Hadzic N, Sidhu PS. Contrast enhanced ultrasound (CEUS) characterization of grey-scale sonographic indeterminate focal liver lesions in pediatric practice. Ultraschall Med. 2013;34(6):529–40.

    Article  CAS  Google Scholar 

  7. Valentino M, Serra C, Pavlica P, et al. Blunt abdominal trauma: diagnostic performance of contrast-enhanced US in children--initial experience. Radiology. 2008;246(3):903–9.

    Article  Google Scholar 

  8. Bonini G, Pezzotta G, Morzenti C, Agazzi R, Nani R. Contrast-enhanced ultrasound with SonoVue in the evaluation of postoperative complications in pediatric liver transplant recipients. J Ultrasound. 2007;10(2):99–106.

    Article  CAS  Google Scholar 

  9. McMahon CJ, Ayres NA, Bezold LI, et al. Safety and efficacy of intravenous contrast imaging in pediatric echocardiography. Pediatr Cardiol. 2005;26(4):413–7.

    Article  CAS  Google Scholar 

  10. Sidhu PS, Cantisani V, Deganello A, et al. Reply: role of contrast-enhanced ultrasound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med. 2017;38:33.

    PubMed  Google Scholar 

  11. Harkanyi Z. Potential applications of contrast-enhanced ultrasound in pediatric patients. Ultrasound Clin. 2013;2013(3):403–22.

    Article  Google Scholar 

  12. Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006;32(9):1369–75.

    Article  Google Scholar 

  13. McCarville MB, Kaste SC, Hoffer FA, et al. Contrast-enhanced sonography of malignant pediatric abdominal and pelvic solid tumors: preliminary safety and feasibility data. Pediatr Radiol. 2012;42(7):824–33.

    Article  Google Scholar 

  14. Riccabona M. Application of a second-generation US contrast agent in infants and children--a European questionnaire-based survey. Pediatr Radiol. 2012;42(12):1471–80.

    Article  Google Scholar 

  15. D’Onofrio M, Crosara S, De Robertis R, et al. Malignant focal liver lesions at contrast-enhanced ultrasonography and magnetic resonance with hepatospecific contrast agent. Ultrasound. 2014;22(2):91–8.

    Article  Google Scholar 

  16. Quaia E, De Paoli L, Angileri R, Cabibbo B, Cova MA. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver. Eur J Radiol. 2014;83(3):456–62.

    Article  Google Scholar 

  17. Trillaud H, Bruel JM, Valette PJ, et al. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol. 2009;15(30):3748–56.

    Article  Google Scholar 

  18. Stenzel M. Intravenous contrast-enhanced sonography in children and adolescents - a single center experience. J Ultrason. 2013;13(53):133–44.

    Article  Google Scholar 

  19. Pschierer K, Grothues D, Rennert J, et al. Evaluation of the diagnostic accuracy of CEUS in children with benign and malignant liver lesions and portal vein anomalies. Clin Hemorheol Microcirc. 2015;61(2):333–45.

    Article  CAS  Google Scholar 

  20. Smith EA, Salisbury S, Martin R, Towbin AJ. Incidence and etiology of new liver lesions in pediatric patients previously treated for malignancy. AJR Am J Roentgenol. 2012;199(1):186–91.

    Article  Google Scholar 

  21. Dietrich CF, Maddalena ME, Cui XW, Schreiber-Dietrich D, Ignee A. Liver tumor characterization--review of the literature. Ultraschall Med. 2012;33(Suppl 1):S3–10.

    PubMed  Google Scholar 

  22. Weinberg AG, Finegold MJ. Primary hepatic tumors of childhood. Hum Pathol. 1983;14(6):512–37.

    Article  CAS  Google Scholar 

  23. Chiorean L, Cui XW, Tannapfel A, et al. Benign liver tumors in pediatric patients - review with emphasis on imaging features. World J Gastroenterol. 2015;21(28):8541–61.

    Article  Google Scholar 

  24. Meyers RL. Tumors of the liver in children. Surg Oncol. 2007;16(3):195–203.

    Article  Google Scholar 

  25. Yikilmaz A, George M, Lee EY. Pediatric hepatobiliary neoplasms: an overview and update. Radiol Clin North Am. 2017;55(4):741–66.

    Article  Google Scholar 

  26. Roebuck DJ, Yang WT, Lam WW, Stanley P. Hepatobiliary rhabdomyosarcoma in children: diagnostic radiology. Pediatr Radiol. 1998;28(2):101–8.

    Article  CAS  Google Scholar 

  27. Mork H, Ignee A, Schuessler G, Ott M, Dietrich CF. Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography. Scand J Gastroenterol. 2007;42(5):652–62.

    Article  Google Scholar 

  28. Trojan J, Hammerstingl R, Engels K, Schneider AR, Zeuzem S, Dietrich CF. Contrast-enhanced ultrasound in the diagnosis of malignant mesenchymal liver tumors. J Clin Ultrasound. 2010;38(5):227–31.

    PubMed  Google Scholar 

  29. Liu GJ, Xu HX, Lu MD, et al. Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology. Br J Radiol. 2007;80(953):321–30.

    Article  Google Scholar 

  30. Dietrich CF, Averkiou MA, Correas JM, Lassau N, Leen E, Piscaglia F. An EFSUMB introduction into dynamic contrast-enhanced ultrasound (DCE-US) for quantification of tumour perfusion. Ultraschall Med. 2012;33(4):344–51.

    Article  CAS  Google Scholar 

  31. Al Bunni F, Deganello A, Sellars ME, Schulte KM, Al-Adnani M, Sidhu PS. Contrast-enhanced ultrasound (CEUS) appearances of an adrenal phaeochromocytoma in a child with Von Hippel-Lindau disease. J Ultrasound. 2014;17(4):307–11.

    Article  Google Scholar 

  32. Ragel M, Nedumaran A, Makowska-Webb J. Prospective comparison of use of contrast-enhanced ultrasound and contrast-enhanced computed tomography in the Bosniak classification of complex renal cysts. Ultrasound. 2016;24(1):6–16.

    Article  Google Scholar 

  33. Drudi FM, Valentino M, Bertolotto M, et al. CEUS time intensity curves in the differentiation between leydig cell carcinoma and seminoma: a multicenter study. Ultraschall Med. 2016;37(2):201–5.

    CAS  PubMed  Google Scholar 

  34. Zhang Y, Luo YK, Zhang MB, Li J, Li J, Tang J. Diagnostic accuracy of contrast-enhanced ultrasound enhancement patterns for thyroid nodules. Med Sci Monit. 2016;22:4755–64.

    Article  Google Scholar 

  35. Defortescu G, Cornu JN, Bejar S, et al. Diagnostic performance of contrast-enhanced ultrasonography and magnetic resonance imaging for the assessment of complex renal cysts: a prospective study. Int J Urol. 2017;24(3):184–9.

    Article  Google Scholar 

  36. Wei SP, Xu CL, Zhang Q, et al. Contrast-enhanced ultrasound for differentiating benign from malignant solid small renal masses: comparison with contrast-enhanced CT. Abdom Radiol (NY). 2017;42:2135.

    Article  Google Scholar 

  37. Sanz E, Hevia V, Gomez V, et al. Renal complex cystic masses: usefulness of contrast-enhanced ultrasound (CEUS) in their assessment and its agreement with computed tomography. Curr Urol Rep. 2016;17(12):89.

    Article  Google Scholar 

  38. Barr RG, Peterson C, Hindi A. Evaluation of indeterminate renal masses with contrast-enhanced US: a diagnostic performance study. Radiology. 2014;271(1):133–42.

    Article  Google Scholar 

  39. Edenberg J, Gloersen K, Osman HA, Dimmen M, Berg GV. The role of contrast-enhanced ultrasound in the classification of CT-indeterminate renal lesions. Scand J Urol. 2016;50(6):445–51.

    Article  Google Scholar 

  40. Putz FJ, Erlmeier A, Wiesinger I, et al. Contrast-enhanced ultrasound (CEUS) in renal imaging at an interdisciplinary ultrasound centre: possibilities of dynamic microvascularisation and perfusion. Clin Hemorheol Microcirc. 2017;66:293.

    Article  CAS  Google Scholar 

  41. Liu Y, Xu Y, Cheng W, Liu X. Quantitative contrast-enhanced ultrasonography for the differential diagnosis of endometrial hyperplasia and endometrial neoplasms. Oncol Lett. 2016;12(5):3763–70.

    Article  Google Scholar 

  42. Gruber L, Loizides A, Luger AK, et al. Soft-tissue tumor contrast enhancement patterns: diagnostic value and comparison between ultrasound and MRI. AJR Am J Roentgenol. 2017;208(2):393–401.

    Article  Google Scholar 

  43. Guo S, Xu P, Zhou A, et al. Contrast-enhanced ultrasound differentiation between low and high-grade bladder urothelial carcinoma and correlation with tumor microvessel density. J Ultrasound Med. 2017;36:2287.

    Article  Google Scholar 

  44. Cantisani V, Bertolotto M, Weskott HP, et al. Growing indications for CEUS: the kidney, testis, lymph nodes, thyroid, prostate, and small bowel. Eur J Radiol. 2015;84(9):1675–84.

    Article  CAS  Google Scholar 

  45. Knieling F, Strobel D, Rompel O, et al. Spectrum, applicability and diagnostic capacity of contrast-enhanced ultrasound in pediatric patients and young adults after intravenous application - a retrospective trial. Ultraschall Med. 2016;37(6):619–26.

    Article  CAS  Google Scholar 

  46. Seitz K, Strobel D. A milestone: approval of CEUS for diagnostic liver imaging in adults and children in the USA. Ultraschall Med. 2016;37(3):229–32.

    Article  CAS  Google Scholar 

  47. Seitz K, Strobel D, Bernatik T, et al. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos. Ultraschall Med. 2009;30(4):383–9.

    Article  CAS  Google Scholar 

  48. Mori N, Mugikura S, Takahashi S, et al. Quantitative analysis of contrast-enhanced ultrasound imaging in invasive breast cancer: a novel technique to obtain histopathologic information of microvessel density. Ultrasound Med Biol. 2017;43(3):607–14.

    Article  Google Scholar 

  49. Tai CJ, Huang MT, Wu CH, et al. Contrast-enhanced ultrasound and computed tomography assessment of hepatocellular carcinoma after transcatheter arterial chemo-embolization: a systematic review. J Gastrointestin Liver Dis. 2016;25(4):499–507.

    PubMed  Google Scholar 

  50. Ishii T, Numata K, Hao Y, et al. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation. Eur J Radiol. 2017;89:234–41.

    Article  Google Scholar 

  51. Bartolotta TV, Taibbi A, Picone D, Anastasi A, Midiri M, Lagalla R. Detection of liver metastases in cancer patients with geographic fatty infiltration of the liver: the added value of contrast-enhanced sonography. Ultrasonography. 2017;36(2):160–9.

    Article  Google Scholar 

  52. Pandey P, Lewis H, Pandey A, et al. Updates in hepatic oncology imaging. Surg Oncol. 2017;26(2):195–206.

    Article  Google Scholar 

  53. Granata V, Fusco R, Catalano O, et al. Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases. PLoS One. 2017;12(6):e0179951.

    Article  Google Scholar 

  54. Maj E, Papiernik D, Wietrzyk J. Antiangiogenic cancer treatment: the great discovery and greater complexity (Review). Int J Oncol. 2016;49(5):1773–84.

    Article  CAS  Google Scholar 

  55. Hendry SA, Farnsworth RH, Solomon B, Achen MG, Stacker SA, Fox SB. The role of the tumor vasculature in the host immune response: implications for therapeutic strategies targeting the tumor microenvironment. Front Immunol. 2016;7:621.

    Article  Google Scholar 

  56. Lee SC, Grant E, Sheth P, et al. Accuracy of contrast-enhanced ultrasound compared with magnetic resonance imaging in assessing the tumor response after neoadjuvant chemotherapy for breast cancer. J Ultrasound Med. 2017;36(5):901–11.

    Article  Google Scholar 

  57. Lassau N, Bonastre J, Kind M, et al. Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study. Invest Radiol. 2014;49(12):794–800.

    Article  CAS  Google Scholar 

  58. Atri M, Hudson JM, Sinaei M, et al. Impact of acquisition method and region of interest placement on inter-observer agreement and measurement of tumor response to targeted therapy using dynamic contrast-enhanced ultrasound. Ultrasound Med Biol. 2016;42(3):763–8.

    Article  Google Scholar 

  59. Amioka A, Masumoto N, Gouda N, et al. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy. Jpn J Clin Oncol. 2016;46(4):303–9.

    Article  Google Scholar 

  60. Saracco A, Szabo BK, Tanczos E, Bergh J, Hatschek T. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy. Acta Radiol. 2017;58(4):394–402.

    Article  Google Scholar 

  61. Matsui S, Kudo M, Kitano M, Asakuma Y. Evaluation of the response to chemotherapy in advanced gastric cancer by contrast-enhanced harmonic EUS. Hepatogastroenterology. 2015;62(139):595–8.

    PubMed  Google Scholar 

  62. Peng C, Liu LZ, Zheng W, et al. Can quantitative contrast-enhanced ultrasonography predict cervical tumor response to neoadjuvant chemotherapy? Eur J Radiol. 2016;85(11):2111–8.

    Article  Google Scholar 

  63. Jia WR, Tang L, Wang DB, et al. Three-dimensional contrast-enhanced ultrasound in response assessment for breast cancer: a comparison with dynamic contrast-enhanced magnetic resonance imaging and pathology. Sci Rep. 2016;6:33832.

    Article  CAS  Google Scholar 

  64. Ohno N, Miyati T, Yamashita M, Narikawa M. Quantitative assessment of tissue perfusion in hepatocellular carcinoma using perflubutane dynamic contrast-enhanced ultrasonography: a preliminary study. Diagnostics. 2015;5(2):210–8.

    Article  CAS  Google Scholar 

  65. Mogensen MB, Hansen ML, Henriksen BM, et al. Dynamic contrast-enhanced ultrasound of colorectal liver metastases as an imaging modality for early response prediction to chemotherapy. Diagnostics. 2017;7(2)

    Google Scholar 

  66. Wu Z, Yang X, Chen L, et al. Anti-angiogenic therapy with contrast-enhanced ultrasound in colorectal cancer patients with liver metastasis. Medicine. 2017;96(20):e6731.

    Article  CAS  Google Scholar 

  67. McCarville MB, Coleman JL, Guo J, et al. Use of quantitative dynamic contrast-enhanced ultrasound to assess response to antiangiogenic therapy in children and adolescents with solid malignancies: a pilot study. AJR Am J Roentgenol. 2016;206(5):933–9.

    Article  Google Scholar 

  68. Ueda N, Nagira H, Sannomiya N, et al. Contrast-enhanced ultrasonography in evaluation of the therapeutic effect of chemotherapy for patients with liver metastases. Yonago Acta Med. 2016;59(4):255–61.

    PubMed  PubMed Central  Google Scholar 

  69. Guvener N, Appold L, de Lorenzi F, et al. Recent advances in ultrasound-based diagnosis and therapy with micro- and nanometer-sized formulations. Methods. 2017;130:4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Imaging, St. Jude Children’s Research Hospital, Memphis, USA

    M. Beth McCarville

  2. Department of Radiology, King’s College Hospital, London, UK

    Annamaria Deganello

  3. Department of Radiology, Heim Pal Children’s Hospital, Budapest, Hungary

    Zoltan Harkanyi

Authors
  1. M. Beth McCarville
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annamaria Deganello
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zoltan Harkanyi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Beth McCarville .

Editor information

Editors and Affiliations

  1. Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA

    Stephan D. Voss

  2. Department of Radiology, Great Ormond Street Hospital for Children, London, UK

    Kieran McHugh

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

McCarville, M.B., Deganello, A., Harkanyi, Z. (2019). Contrast-Enhanced Ultrasound: The Current State. In: Voss, S., McHugh, K. (eds) Imaging in Pediatric Oncology. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-03777-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-03777-2_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-03776-5

  • Online ISBN: 978-3-030-03777-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation